Drugs / MRC375
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01408602 | Nov 2011 → Jul 2014 | rheumatoid arthritis | Molecular Research Center, Inc. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MRC375 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01408602 ↗ |
| Known as | Tetracycline | “MRC375 (enteric coated Tetracycline) 150mg 3 times a day for 24 weeks.” NCT01408602 ↗ |